Picture of Orchid Pharma logo

ORCHPHARMA — Orchid Pharma News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Orchid Pharma Enters Into Manufacturing Sublicense Agreement With Global Antibiotic Research & Development Partnership

Sept 12 (Reuters) - Orchid Pharma Ltd  ORCD.NS :
    * ENTERED INTO MANUFACTURING SUBLICENSE AGREEMENT WITH
GLOBAL
ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP
    * AGREEMENT TO MANUFACTURE CEFIDEROCOL, AN ANTIBIOTIC TO
TREAT
CERTAIN GRAM-NEGATIVE INFECTIONS

Source text for Eikon:  ID:nBSE3FZshw 
Further company coverage:  ORCD.NS 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Orchid Pharma

See all news